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ABSTRACT 
Objective: The objective of this study is to see the 
distribution of parity in females with epithelial ovarian 
tumours and also see whether there has been defensive 
impact of expanding parity. 
Materials and Methods: This descriptive study was 
carried out at Institute Sir Ganga Ram Hospital, Lahore 
and THQ Hospital, Sarai Alamgir during the period from 
01.07.2017 to 31.12.2017. All patients over nineteen 
years of age who experienced laparotomy for a presumed 
ovarian tumour and consequently whose 
histopathological report ended up being of an epithelial 
ovarian tumour (N=124) were incorporated into the 
investigation. In these patients, distribution of parity was 
noted. 
Results: Distribution of parity was 32 (26%) nullipara, 
92 (74%) multipara, females with 1-4 parity were 54 
(44%) and above five with parity were 38 (30%). In 
ovarian carcinoma patients maximum had parity of three 
and eight.  
Conclusion: In our country, it appears that nulli-parity in 
the aetiology of both benign as well as malignant 
epithelial ovarian tumours is not a significant factor and 
expanding parity has not been defensive / protective for 
females. 
Key words: Ovarian Tumours, Parity, Ovarian 
Cancer, Epithelial Tumours, Nulli-Parity, Multi-
Parity. 
INTRODUCTION 
In the developed world, ovarian cancer 
influences somewhere in the range of one and two 
percent females. It is the most deadly 
gynaecological harm having a mortality rate 
proportion of 0.675. Varieties in the rates of 
ovarian malignancy around the globe are less set 
apart than for other gynaecological disease.[1] In 
Pakistan, third most general malignancy is ovarian 
carcinoma. In Pakistan, it represents 18% to 23% 
of all women cancers and thirty four percent of all 
gynaecological cancers.[2-3] 
 Around eighty percent of cancers are 
adeno-carcinomas. Before the age of thirty five 
years, they are uncommon; however, incidence rate 
increases with age to a crest in the fifty years to 
seventy years of age gathering. Simply under half 
happen in females matured 45-years to 65-years.[4] 
At the age of slightly younger, benign epithelial 
tumour occur than their malignant counter-parts. 
They are most regular in females more than forty 
years.[5] 
The elements which causes ovarian 
tumour are not known. With nulli-parity, epithelial 
tumours are most oftentimes associated, an early 
menarche, a late age at menopause and a since a 
long time ago assessed number of long periods of 
ovulation.[6] Between neoplasia and ovarian 
stimulation proposed causal relationship depends 
on three primary hypotheses. The most generally 
acknowledged hypotheses is Fathalla’s incessant 
ovulation hypothesis. It proposes that repeated 
ovulation resulted epithelial ovarian carcinoma, 
where the total impacts of every minor trauma on 
ovarian epithelium can prompt harmful change.[7] 
This  recommends the danger of ovarian 
malignancy is straight forwardly corresponding to 
the quantity of ovulatory cycles among the 
menarche and menopause. 2nd theory proposes that 
industrious presentation of the ovary to exogenous 
gonadotrophins or endogenous or related to 
optionally raised oestradiol fixations, might be 
straight forwardly cancer-causing. In vitro 
considers have demonstrated that gonadotrophins 
fortify deoxyribonucleic corrosive (DNA) 
amalgamation and multiplication in various ovarian 
disease cell lines and furthermore altogether 
increment protein Kinase C movement in these 
tumours.[8] The 3rd speculation  identifies with the 
creation of synthetic cancer-causing agents inside 
the nearby ovarian condition after incitement with 
gonadotrophins and oestrogens. In animated 
granulose cells the microsomal P 450 cytochrome 
subordinate hydroxylation frameworks can change 
over aromatic polycyclic hydrocarbons into 
receptive hypoxides. These can wreck follicular 
cells and cause threatening change by shaping 
covalent bonds with proteins and DNA.[9] 
  Between ovarian cancer and infertility, 
there is a relationship. The connection gives off an 
impression of being most grounded in females with 
un-explained fertility and in females who have not 
possessed the capacity to end up pregnant at all.[10] 
Diminishing risk with expanding number of full 
term pregnancies has been reliably appeared in 
over dozen of case controlled investigations. 
According to a United State investigation, there 
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was one kid who was associated with a decrease in 
risk i.e. 40%, two kids with decrease in risk 60% 
and five or more with 80% decrease. Ovarian 
surface epithelial cell apoptosis initiated by 
hormones of pregnancy might be the basic 
defensive instrument.[11] 
  As compared to western females, 
Pakistani females have higher parity. There is an 
ongoing pattern towards reproduce a lesser number 
of children in our females. In perspective of high 
mortality and morbidity allied with epithelial 
ovarian tumour, the aim of this investigation was to 
watch the parity distribution in females who 
diagnosed with epithelial ovarian tumour and to 
think about the frequencies of tumour in 
nulliparous & multiparous females to see if a 
higher parity had truly been defensive in our 
females. 
MATERIALS AND METHODS  
This descriptive study was conducted at 
Institute Sir Ganga Ram Hospital, Lahore and THQ 
Hospital, Sarai Alamgir from 01.07.2017 to 
31.12.2017. In diameter 7.9CM asymptomatic echo 
free ovarian cysts’ patients was included in this 
study, any size of asymptomatic ovarian cysts 
which are not echo free are multilocular or have 
septa, papillary formation or solid parts, any size of 
asymptomatic ovarian cysts allied with raised 
serum CA125 levels or any size of symptomatic 
ovarian cysts allied with signs / indications like 
intra-peritoneal bleeding signs or acute pain or 
torsion. The patients were excluded from the study 
according to exclusion criteria who were 
asymptomatic, echo free, simple, papillary 
formations or without solid parts of unilateral 
ovarian cysts, in diameter less than 8CM and 
normal levels of CA125 and those women who 
have less than nineteen years of age. After 
obtaining the informed consent, all patients visiting 
the hospital during the study period who have age 
of 19-years and above the age of nineteen years 
(menopausal & reproductive age group) underwent 
laparotomy in accordance with inclusion criteria. 
At pathology department of hospital, ovarian mass 
histopathology was done and females who ended 
up having epithelial ovarian tumour were 
incorporated into the investigation. According to 
the World Health Organization (WHO) proposed 
classification, tumours histological characterization 
was done. According to parity patients were 
divided into three groups. The three gatherings 
were nullipara, females with one to four parity and 
females with five and above parity. A Proforma 
was intended to fill the patients relevant 
information. SPSS software was used to analyze 
the data. For each parity group percentages and 
frequencies were calculated and to see the 
significance statistically of frequencies difference 
of epithelial ovarian tumour among multiparous 
and nulliparous females at level of 0.05 
significance, the chi-square test was applied. 
RESULTS  
Epithelial ovarian tumours were diagnosed 
in 124 patients in the menopausal and reproductive 
age group; nineteen years and above. 18 (15%) 
patients were menopausal and there were 106 
(85%) patients in reproductive age group in this 
investigation. In 88 (71%) patients, epithelial 
ovarian tumours were seen at benign stage and in 
36 (29%) of the patients ovarian carcinoma was 
observed. The diverse histological kinds of 
epithelial ovarian tumours seen were 64 (51%) 
serous cyst-adenomas, 24 (19%) mucinous cyst-
adenomas, serous cyst-adenocarcinoma 16 (13%), 
6 (5%) endometrioid carcinoma, mucinous cyst-
adenocarcinoma 12 (10%) and 2 (2%) un-
differentiated carcinoma. 
Parity distribution was nullipara 32 (26%) 
in patients who suffering from epithelial ovarian 
tumour, 92 (74%) multipara, 54 (44%) had one to 
four parity and 38 (30%) had more than five parity. 
In patients experiencing epithelial ovarian tumours 
at benign stage 24 (27%) of the females were 
nulliparous while multiparous were 64 (73%). 1 to 
4 parity was found in 40 (45%) while more than 5 
parity was seen in 24 (27%). 8 (22%) were 
nulliparous among patients who suffer from 
epithelial tumours at malignant stage, multiparous 
were 28 (78%), parity extending 1 to 4 in 14 (39%) 
patients and parity above 5 in the similar patient’s 
number 14 (39%). 
Patients who have parity of two had the 
lowest percentage of epithelial tumours at benign 
stage 2 (3%) while 4-parity patients had greatest 
number of tumours at benign stage 18 (28%). There 
was seen no parity relationship with frequency of 
tumours at benign stage. In instances of ovarian 
carcinoma none of the patients has parity of four, 
while greatest number of patients with parity of 
three and eight apparently suffered from ovarian 
carcinoma 6 (22%) for each gathering. Age group 
of menopausal, we had 18-patients, out of these 
nulliparous was 2 (11%) and grand multipara were 
16 (89%) having above than four children. 
In this study there were 80 patients who 
suffer from serous ovarian tumours and mucinous 
ovarian tumours in 36 patients. Nullipara parity 
distribution was observed in patients 6 (17%) who 
suffer from mucinous tumours, one to four parity in 
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12 (33%), and above five parity in 18 (50%) 
patients. 26 (32%) were nullipara in patients who 
were diagnosed with serous tumours, 22 (28%) 1 to 
4 parity and five or more parity in 32 (40%). There 
were greatest number of patients who had parity of 
five and more in both histological types. 
Shockingly in both generous and 
threatening epithelial ovarian tumours greatest 
number of patients was seen in multipara 
contrasted with nullipara and expanding parity 
appeared to have no defensive impact. Rather, 
multipara apparently had most noticeably awful 
ovarian tumours prevalence. 
DISCUSSION 
Nulli-parity is thought to be a hazard 
factor for the advancement of ovarian carcinoma. A 
large portion of the western examinations have 
demonstrated that nulliparous ladies have high 
occurrence of ovarian cancer. As indicated by these 
examinations multi-parity was related with a huge 
decrease in danger of ovarian cancer and the high 
danger of ovarian malignancy is contrarily 
identified with the quantity of full term pregnancies 
and each extra kin as related with a hazard 
decrease.[12-17] Be that as it may, the larger part of 
our patients determined to have epithelial ovarian 
tumours 92 (74%) were multipara and a lesser 
number of patients ended up being nulliparous. In 
patients experiencing ovarian carcinoma 28 (78%) 
were multipara and 8 (22%) were nullipara. In 
patients experiencing epithelial ovarian carcinoma 
14 (39%) had parity of one to four and a similar 
rate 14 (39%) had parity of five or more. 
Strangely, the level / percentage of 
females with at least five children 14 (39%) were 
more prominent than the individuals who were 
nulliparous 8 (22%). This discovering demonstrates 
no defensive / protective impact of expanding 
parity on the danger of epithelial ovarian 
carcinoma. 
There was less number of nullipara 
patients 24 (27%) in the group of epithelial ovarian 
tumours patients at benign stage while large part of 
patients was multipara 64 (73%). The extent of 
females who were nulliparous was relatively same 
in patients with considerate epithelial tumours 27% 
and those with epithelial ovarian carcinoma 22%. 
This demonstrate the parity range is comparative 
for benign & malignant both epithelial ovarian 
tumours. 
The outcomes of our study are similar 
with the recent Pakistani investigation conducted at 
Karachi, Lahore and Rawalpindi.[18-20] Our findings 
are also similar with an examination conducted at 
Nigeria-Ibadan.[21] An examination carried out by 
Nieto JJ et-al did not discover any confirmation of 
a distinction in dysplasia score between nulliparous 
females and controls neither before nor in the wake 
of modifying for age.[22] 
Conclusion 
It appears in both benign and malignant 
epithelial ovarian tumours aetiology that multi-
parity is not a significant factor / element and in 
our country, expanding parity has not been 
defensive / protective for females. 
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